COYA Coya Therapeutics Inc: Biji pasar

The price chart for Coya Therapeutics, Inc. (COYA) clearly illustrates the approach to automating Treg cell analysis via IT platforms for drug discovery. The price action, where the market capitalization stands at 0.10, depends exclusively on the progress of clinical trials, ignoring macroeconomic factors. The business relies on innovative Treg therapy that restores immunity to combat amyotrophic lateral sclerosis, unlocking new opportunities in the treatment of neurodegeneration.

Coya Therapeutics Inc - Kapitalisasi pasar COYA (periode 28.04.2023 - 22.10.2026)

COYA (coyatherapeutics.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Coya Therapeutics, Inc. (COYA):

Bagan rega Coya Therapeutics|COYA - Rata-rata rega prakiraan|Biji pasar COYA

Analisis fundamental perusahaan:COYA (Coya)

Sampel barang Coya Therapeutics Inc

Market capitalization reflects the aggregate value of all shares, reacting instantaneously to market sentiment and liquidity. Analyzing volatility through the issuer's current capitalization allows for an assessment of the asset's resilience to panic selling. The trend of this metric determines the balance between growth potential and the risks of capital freeze. For Coya Therapeutics, Inc. (COYA), this metric visualizes the market valuation of breakthrough developments in neuroprotection. The company's value depends directly on the prospects of T-cell therapy for Alzheimer's and ALS.

Pesaing wigati

Nilai pasar Biogen BIIB|Neurocrine (NBIX) - Nilai pasar|RGC: Biji pasar|Nilai pasar Axsome Corp|ACAD: Kapitalisasi pasar|xenon-pharma.com (XENE) - Kapitalisasi pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Biji pasar Prothena Corp (PRTA)|Nilai pasar Alector, Inc. (ALEC)|ANNX - Nilai pasar|Omeros - Biji pasar|Neurogene Therapeutics (NGNE) - Nilai pasar|AC Immune - Kapitalisasi pasar|VYGR - Kapitalisasi pasar|NMRA (Neumora Therapeutics, Inc.) - Biji pasar|Scilex Holding - Nilai pasar|Biji pasar TVGN|ACOG (Alpha Cognition Corp) - Nilai pasar|Kapitalisasi pasar CGTX|IKT (inhibikase.com) - Nilai pasar|Kapitalisasi pasar SAVA (Cassava Sciences)|Assertio Holdings (ASRT) - Nilai pasar|VTGN - Nilai pasar|Nilai pasar OVID (Ovid Therapeutics Inc.)|ABOS: Kapitalisasi pasar|cervomed.com (CRVO) - Kapitalisasi pasar|Nilai pasar Alterity Therapeutics Ltd.|Clene Nanomedicine - Biji pasar|Kapitalisasi pasar PEPG|JUNS - Nilai pasar|Relmada Therapeutics - Biji pasar|Kapitalisasi pasar annovisbio.com ANVS|GRCE: Biji pasar|Firefly Neuroscience, Inc. - Nilai pasar|KLTO: Kapitalisasi pasar|NRSN - Kapitalisasi pasar|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|Biji pasar MetaVia, Inc. (MTVA)|Nilai pasar NeurAxis (NRXS)|Kapitalisasi pasar heliusmedical.com|Passage Bio - Biji pasar|Nilai pasar NEUP|Minerva Neurosciences - Kapitalisasi pasar|Kapitalisasi pasar athira.com ATHA|Addex Therapeutics Ltd (ADXN) - Nilai pasar|Kapitalisasi pasar ALZN|CYCN (Cyclerion Therapeutics Inc.) - Kapitalisasi pasar|Biji pasar Protagenic (PTIX)|Biji pasar KTTA (Pasithea Therapeutics)|Kapitalisasi pasar cortigent.com|Kapitalisasi pasar ATXI (Avenue Therapeutics, Inc.)|BCLI - Biji pasar|CARA - Nilai pasar|Nilai pasar Chromocell|ELYM (eliemtx.com) - Biji pasar|Nilai pasar Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Marinus Pharmaceuticals Inc|Nilai pasar NKGen (NKGN)|NeuroBo Pharma - Kapitalisasi pasar|Kapitalisasi pasar SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Nilai pasar|TRVN: Biji pasar|VIGL - Kapitalisasi pasar|Anew Medical, Inc. (WENA) - Nilai pasar|Cerevel Corp - Nilai pasar